We are live on ! Find out more
BC

Bridgefront Capital Portfolio holdings

AUM $402M
1-Year Est. Return 18.17%
This Fund
S&P 500
This Quarter Est. Return
-3.98%
1 Year Est. Return
+18.17%
3 Year Est. Return
+38.15%
5 Year Est. Return
+29.06%
10 Year Est. Return
AUM
$346M
AUM Growth
+$49.6M
Cap. Flow
+$70.7M
Cap. Flow %
20.43%
Top 10 Hldgs %
7.63%
Holding
891
New
341
Increased
142
Reduced
107
Closed
301

Top Buys

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$2.77M
2
INTU icon
Intuit
INTU
+$2.66M
3
HPQ icon
HP
HPQ
+$2.64M
4
HON icon
Honeywell
HON
+$2.37M
5
ETR icon
Entergy
ETR
+$2.12M

Top Sells

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$2.46M
2
SLB icon
SLB Ltd
SLB
+$2.21M
3
RSG icon
Republic Services
RSG
+$2.14M
4
GIS icon
General Mills
GIS
+$1.95M
5
MSFT icon
Microsoft
MSFT
+$1.91M

Sector Composition

Rank Sector Weight
1 Technology 16.17%
2 Industrials 13.96%
3 Healthcare 13.19%
4 Consumer Discretionary 12.89%
5 Financials 12.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALGN icon
601
Align Technology
ALGN
$12B
-1,740
Closed -$363K
ALIT icon
602
Alight
ALIT
$497M
-2,559
Closed -$354K
ALL icon
603
Allstate
ALL
$66.9B
-5,991
Closed -$1.16M
AMCR icon
604
Amcor
AMCR
$20.6B
-13,125
Closed -$618K
AMGN icon
605
Amgen
AMGN
$203B
-5,929
Closed -$1.55M
AMP icon
606
Ameriprise Financial
AMP
$46.8B
-416
Closed -$221K
AMX icon
607
America Movil
AMX
$78.1B
-23,633
Closed -$338K
AMZN icon
608
Amazon
AMZN
$2.5T
-2,680
Closed -$588K
ANAB icon
609
AnaptysBio
ANAB
$1.6B
-19,011
Closed -$252K
ANIP icon
610
ANI Pharmaceuticals
ANIP
$1.77B
-3,692
Closed -$204K
APH icon
611
Amphenol
APH
$188B
-7,609
Closed -$528K
ARLO icon
612
Arlo Technologies
ARLO
$1.4B
-12,576
Closed -$141K
AROC icon
613
Archrock
AROC
$6.33B
-9,336
Closed -$232K
ASB icon
614
Associated Banc-Corp
ASB
$5.81B
-10,007
Closed -$239K
EFOR
615
Everforth Inc
EFOR
$845M
-6,140
Closed -$512K
ASPN icon
616
Aspen Aerogels
ASPN
$387M
-20,427
Closed -$243K
AUB icon
617
Atlantic Union Bankshares
AUB
$5.99B
-7,916
Closed -$300K
AUPH icon
618
Aurinia Pharmaceuticals
AUPH
$1.97B
-16,606
Closed -$149K
AVNT icon
619
Avient
AVNT
$3.45B
-5,767
Closed -$236K
AVPT icon
620
AvePoint
AVPT
$2.6B
-23,959
Closed -$396K
AX icon
621
Axos Financial
AX
$5.45B
-2,879
Closed -$201K
DCH
622
Dauch Corp
DCH
$1.3B
-26,818
Closed -$156K
AXTA icon
623
Axalta
AXTA
$7.01B
-25,488
Closed -$872K
AXSM icon
624
Axsome Therapeutics
AXSM
$12.4B
-10,555
Closed -$893K
AZN icon
625
AstraZeneca
AZN
$263B
-1,625
Closed -$213K

Similar funds

Bridgefront Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Bridgefront Capital held 891 positions worth $346M, up 17% from $297M the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

Bridgefront Capital deployed $70.7M of net new capital in Q1 2025, opening 341 new positions and adding to 142 existing holdings. Its largest new stake was Equinix: 3,081 shares worth $2.51M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was TJX Companies, an estimated $2.46M trimmed.

  • Bridgefront Capital's largest Q1 2025 buy was Equinix: 3,081 shares worth $2.51M.
  • Bridgefront Capital added most to Owens Corning in Q1 2025, an estimated $2.06M increase.
  • Bridgefront Capital's biggest Q1 2025 reduction was TJX Companies, cutting an estimated $2.46M.
  • Bridgefront Capital fully exited SLB Ltd in Q1 2025, selling an estimated $2.21M.
  • Bridgefront Capital's ten largest holdings make up 7.6% of its $346M portfolio in Q1 2025.
  • Bridgefront Capital opened 341 new positions and closed 301 in Q1 2025.
  • Bridgefront Capital's portfolio value rose 17% quarter-over-quarter to $346M.

Based on Bridgefront Capital's 13F filing for Q1 2025, filed 15 May 2025.